A Phase I Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD4144

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This Phase I, open-label, parallel group study will investigate the single oral dose PK, safety, and tolerability of AZD4144 to male and female participants with mild, moderate, and severe hepatic impairment compared to matched controls with normal hepatic function.
Epistemonikos ID: 9c545122ad4f187ae65281aeee173002ce87ba24
First added on: Aug 26, 2026